Plain-English translation of NCT07199127 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is working to improve how doctors identify dangerous polyps in the small intestine (duodenum) of people with familial adenomatous polyposis (FAP). Researchers are developing a new classification system that could better predict who is at risk for cancer, so doctors can treat patients earlier and more effectively. The study uses information from past endoscopy procedures to build and test this improved system.
The current system doctors use to classify duodenal polyps, called the Spigelman staging system, was created in 1989 and has significant limitations—it misses cancer in about half of cases and doesn't reliably predict which patients will develop dangerous changes that could turn into cancer. This study exists to create a better tool that catches problems earlier, when minimally invasive treatments are still possible.
You likely qualify if…
You likely don't qualify if…
Researchers will review your past endoscopy records and biopsy results to understand your polyp history over time. You will not need to undergo new procedures—this is purely a data review study. Your information will be grouped with hundreds of other FAP patients to help develop and validate this new classification system.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Italy